Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
Perceived Exertion Is Lower When Using a Functional Electrical Stimulation Neuroprosthesis Compared With an Ankle-Foot Orthosis in Persons With Multiple Sclerosis: A Preliminary Study.
Re: S Shahrbanian, M Auais, P Duquette, K Anderson, NE Mayo. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis. Pain Res Manag 2013;18(5):e94-e100.
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
CNS myelin structural modification induced in vitro by phospholipases A2.
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Clinical and epidemiological profiles of non-traumatic myelopathies.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »